Comment on "Cutting Edge: Inhibiting TBK1 by Compound II Ameliorates Autoimmune Disease in Mice"

J Immunol. 2016 Jan 15;196(2):530-1. doi: 10.4049/jimmunol.1502255.

Authors

David Brenner¹, Peter M Andersen², Albert C Ludolph¹, Jochen H Weishaupt³

Affiliations

¹ Department of Neurology, Ulm University, 89081 Ulm, Germany; and.
² Department of Neurology, Ulm University, 89081 Ulm, Germany; and Department of Pharmacology and Clinical Neuroscience, Umeå University, 90187 Umeå, Sweden.
³ Department of Neurology, Ulm University, 89081 Ulm, Germany; and [email protected].

PMID: 26747568
DOI: 10.4049/jimmunol.1502255

No abstract available

Publication types

Letter
Comment

MeSH terms

Animals
Autoimmune Diseases / drug therapy*
Humans
Interferons / immunology*
Protein Kinase Inhibitors / therapeutic use*
Protein Serine-Threonine Kinases / antagonists & inhibitors*

Substances

Protein Kinase Inhibitors
Interferons
Protein Serine-Threonine Kinases